Press Releases:
February 27, 2007 - Vaxiion Therapeutics, Inc. Granted Broad Patent Protection for Breakthrough Vaccine Delivery System.
March 8, 2007 - Vaxiion Researchers Discover Novel Vaccine Delivery System in Collaboration with San Diego State University
Publications:
1. Giacalone, M. J., N. L. Berkley, B. T. Lovitt, A. M. Gentile, C. W. Gunderson and M. W. Surber. 2006. Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. Biotechniques, 40:355-364, March, 2006.
2. Giacalone, M. J., A. M. Gentile, B. T. Lovitt, M. W. Surber, R. A. Sabbadini. 2006. The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells. Cellular Microbiology (2006), 8(10), 1624-1633.
3. Giacalone, M. J., S. Pillai, A. L. Chambers, R. A. Sabbadini, K. McGuire. 2006. Antigen-specific antibody production generated by bacterial minicells. Vaccine, 24 (2006), 6009-6017.
4. Giacalone M.J., Sabbadini, R.A., Zapata, J.A., Chu Y.L., Berkley, N.L., Salvato M.S., and McGuire, K. Mucosal immunization with minicells co-delivering Lymphocytic Choriomeningitis Virus Nucleoprotein and the corresponding DNA vaccine results in protective immunity. Vaccine, 25;12 (2007), 2279-2287.